No Data
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
IMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress
12 Health Care Stocks Moving In Friday's After-Market Session
Insight Molecular Diagnostics Balances Progress and Cash Burn
BTIG Maintains Insight Molecular Diagnostics(IMDX.US) With Hold Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Aquestive Therapeutics (AQST), Sangamo Therapeutics (OtherSGMO) and Insight Molecular Diagnostics (IMDX)